Request Trial

Latest News & Features

Reset all filters
Article Type
Channels & Sectors
Geography
Company
Refine Search
Patent term restoration and adjustment in Mexico: a TPP possibility?
Americas
Patent term restoration and adjustment in Mexico: a TPP possibility?
Patent term restoration has been adopted by several jurisdictions, with varying success. Mexico faces several issues with sanitary authorisations and patent examination, so patent term restoration would be a viable remedy for patent holders. The TPP might enable this.   30 April 2013
Obviousness of DNA fragments in the post-Kubin era
Americas
Obviousness of DNA fragments in the post-Kubin era
James Monroe and Lawrence Ilag of Finnegan, Henderson, Farabow, Garrett & Dunner LLP analyse the impact of the US Court of Appeals for the Federal Circuit’s decision In re Kubin.   30 April 2013
Considerations for biopharma under a first-inventor-to-file regime
Americas
Considerations for biopharma under a first-inventor-to-file regime
The sweeping reform brought about by the AIA includes the FITF patent system, which places a premium on maintaining confidentiality, and speed and efficiency in filing patent applications while juggling the uncertainties and nuances of this new system.   1 April 2013
Americas
Who's first? New rules on filing patents
On March 16, 2013, the ‘first inventor to file’ provisions of the AIA came into effect. MaryAnne Armstrong looks at the implications.   1 April 2013
Biotechnology
Biotech threats in the SPC system
In its effort to tackle the threat of ‘evergreening’, the CJEU has caused some uncertainty about supplementary protection certificates, as Jaap Mannaerts explains.   1 April 2013
Americas
Post-grant patent challenges in Europe and the US: harmony at last?
Challenging the validity of a patent through the court systems of Europe and the US can be a time-consuming and expensive process. Jane Wainwright and Daniel Young look at the alternatives.   1 April 2013
Americas
Moving forward: biologics and biocomparables in Mexico
Biocomparable medicines are currently among the hottest topics in regard to life sciences legislation in Mexico. Daniel Sánchez and Victor Ramirez investigate.   1 April 2013
Asia
Patent protection of traditional knowledge and biological material
Therapeutic substances used under the folk medicine practices of what is known as ‘traditional knowledge’ are protected by special provisions under Indian patent law. Archana Shanker and Vidisha Garg explore the pros and cons.   1 April 2013
Asia
Slow but positive change? The evolution of section 3d
New definitions of efficacy are helping to clarify pharmaceutical patent challenges under the notorious Section 3d of the Indian Patents Act, says Rahul Vartak.   1 April 2013
Europe
The European take on the Bolar provision: conclusions from Astellas v Polpharma
While changes to European law seem to allow fairly broad exemptions to the patent law for companies developing generic alternatives to branded drugs, the reality is different, as Rafał Witek explains.   1 April 2013